Q2 2023 13F Holders as of 30 Jun 2023
-
Type / Class
-
Equity / COM
-
Number of holders
-
23
-
Total 13F shares, excl. options
-
628,750
-
Shares change
-
-198,761
-
Total reported value, excl. options
-
$6,063,402
-
Value change
-
-$2,464,652
-
Number of buys
-
10
-
Number of sells
-
-12
-
Price
-
$9.64
Significant Holders of Greenwich LifeSciences, Inc. - COM (GLSI) as of Q2 2023
29 filings reported holding GLSI - Greenwich LifeSciences, Inc. - COM as of Q2 2023.
Greenwich LifeSciences, Inc. - COM (GLSI) has 23 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 628,750 shares
.
Largest 10 shareholders include VANGUARD GROUP INC (282,215 shares), RENAISSANCE TECHNOLOGIES LLC (79,200 shares), AMERIPRISE FINANCIAL INC (68,192 shares), BlackRock Inc. (57,575 shares), GEODE CAPITAL MANAGEMENT, LLC (39,933 shares), MILLENNIUM MANAGEMENT LLC (35,348 shares), GSA CAPITAL PARTNERS LLP (33,409 shares), STATE STREET CORP (13,002 shares), HRT FINANCIAL LP (10,136 shares), and BANK OF AMERICA CORP /DE/ (5,060 shares).
This table shows the top 23 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.